Quarterly report pursuant to Section 13 or 15(d)

Equity-Based Compensation - Summary of Options (Details)

v3.22.2.2
Equity-Based Compensation - Summary of Options (Details)
9 Months Ended
Sep. 30, 2022
$ / shares
shares
Shares  
Outstanding, beginning balance (in shares) | shares 1,546,400
Granted options (in shares) | shares 959,618
Exercised (in shares) | shares 0
Forfeitures (in shares) | shares (105,300)
Outstanding, ending balance (in shares) | shares 2,400,718
Weighted-Average Grant Date Fair Value per Share  
Outstanding, beginning balance (in dollars per share) $ 3.32
Granted (in dollars per share) 1.80
Exercised (in dollars per share) 0
Forfeited (in dollars per share) 3.32
Outstanding, ending balance (in dollars per share) 2.71
Weighted-Average Exercise Price per Share  
Outstanding, ending balance (in dollars per share) 7.25
Granted (in dollars per share) 3.13
Exercised (in dollars per share) 0
Forfeited (in dollars per share) 10.03
Outstanding, beginning balance (in dollars per share) $ 10.00
Weighted-Average Remaining Contractual Term (Years) 9 years 3 months